Ole Kring

Ole Kring

Investment Director

Responsible for business development of the investment portfolio in Life Science. Former Founder, CEO and President of Zoetis Denmark (Scandinavian Micro Biodevices / SMB), Vice President of Alere Inc., Adm. Director / Vice President of NKT Innovation, Executive Assistant at NKT Holding, Project Manager and Telemarketing Manager in Q8 and Management consultant at A.T. Kearney and Project Manager in Lessor. Graduate MSc, Economics & Business Administration from Copenhagen Business School.

Portfolio

Nanovi

Nanovi has developed soft tissue markers to enhance precision and raise standards for better outcomes in radiotherapy and surgery.

OBI Medical

The med-tech company OBI Medical had developed a ground breaking v-TAC technology to calculate arterial blood gas in a regular blood test.